Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Sepantronium Bromide for the Treatment of High-grade B-cell LymphomaB-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Disease Attributes, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Lymphoma, High-Grade, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Tumor Virus Infections, diffuse large B-cell lymphoma, high grade B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, viral infectious diseaseActive, not recruitingPhase 22025-01-14NCT05263583

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Cothera Bioscience, Inc1

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Beijing Cancer HospitalBeijingChina85
Dong-A University HospitalBusanSouth Korea20
Henan Cancer HospitalHenanChina6
Inje University Haeundae Paik HospitalBusanSouth Korea8
Samsung Medical CenterSeoulSouth Korea170
Seoul National University HospitalSeoulSouth Korea183
Seoul St.Mary's HospitalSeoulSouth Korea1
Shanghai East HospitalPudongChina1
Sun Yat-Sen University Cancer CenterGuangzhouChina66
Tianjin Cancer HospitalTianjinChina10
Tongji HospitalWuhanChina5